B. Riley Securities initiated coverage on Whitehawk Therapeutics with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for WHWK
Across the 21 sessions after earlier WHWK headlines, the stock closed higher 8 times and lower 13 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WHWK | SPY |
|---|---|---|---|
| Jun 1, 2026 | Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 | -4.9% | +0.3% |
| May 29, 2026 | Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference | -1.3% | +0.2% |
| May 22, 2026 | Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload | +4.4% | +0.4% |
| May 20, 2026 | Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | +3.7% | +1.0% |
| May 15, 2026 | Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum | -7.8% | -1.2% |
| May 13, 2026 | Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing | +25.8% | +0.6% |
Quantisnow market dataNASDAQ
WHWK
Whitehawk Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for WHWK
Full WHWK profile on Quantisnow Follow WHWK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time